A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Low Dose Cytarabine in the Treatment of High-risk Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)
- Status
- COMPLETED
- Phase
- PHASE3
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE1
Azacitidine, Darbepoetin Alfa, and Erythropoietin and Filgastrim (G-CSF) in Treating Patients With Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2
DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease
- Status
- TERMINATED
- Phase
- PHASE2
A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2
Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1
Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2
Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases
- Status
- COMPLETED
- Phase
- NA
Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases
- Status
- TERMINATED
- Phase
- PHASE1
Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
MGCD0103 in Elderly Patients With Previously Untreated AML/High Risk MDS or Adults With Relapsed/Refractory Disease
- Status
- TERMINATED
- Phase
- PHASE2
Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- EARLY_PHASE1